Value Partners’s Exact Sciences EXAS Stock Holding History

Value Partners’s Portfolio EXAS Stock Details EXAS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-12,300	Closed	-$337K	–	14
2014 Q4	$337K	Buy	+12,300	New	+$299K	0.55%	28

Other funds holding EXAS

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

GGHC

Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

JPCCM

J&P (China) Capital Management Hong Kong, China $586M AUM 82.64% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Value Partners's EXAS Position: Q1 2015 in Review

Value Partners sold out of Exact Sciences (EXAS) in Q1 2015, closing a stake of 12,300 shares — an estimated $337K sold.

Value Partners first reported a position in EXAS in Q4 2014 and held it in 1 quarter. The position peaked at $337K in Q4 2014. 182 funds tracked by Wall St. Rank hold EXAS as of Q1 2015.

Value Partners reported no remaining Exact Sciences position as of Q1 2015 after selling out during the quarter.
Value Partners sold 12,300 Exact Sciences shares in Q1 2015, an estimated $337K.
Value Partners first reported a position in Exact Sciences in Q4 2014 and held it in 1 quarter.
Value Partners's Exact Sciences position peaked at $337K in Q4 2014.
182 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2015.

Based on Value Partners's 13F filing for Q1 2015, filed 13 May 2015.